Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUI and text updates include adding a glossary toggle (Show/Hide glossary), adjusting the QC criterion label from previous wording to a new one, and adding 'No FEAR Act Data' and 'Revision: v3.4.0' notes. These changes do not affect the study content or critical study information.SummaryDifference0.1%

- Check21 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Locations section was updated with a large number of new trial sites across multiple countries (US, Canada, Europe, Asia, Australia, and South America), expanding where patients may enroll. At the same time, many existing locations were removed, indicating a restructuring of site availability.SummaryDifference4%

- Check70 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This appears to be a minor backend/UI update and does not change the study content or results.SummaryDifference0.0%

- Check77 days agoChange DetectedPublications are provided voluntarily by the person entering information and are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study. Revision updated from v3.2.0 to v3.3.1, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check85 days agoChange DetectedRemoved the banner about a lapse in government funding and directions to cc.nih.gov and opm.gov for updates.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.